JNC :: Journal of Neurocritical Care

| Home | E-Submission | Sitemap | Contact Us |

Review Article

December 30, 2024

Principle of intravenous fluid therapy in the neurocritically ill patients

Sang-Bae Ko

J Neurocrit Care. 2024;17(2):41-48.

Intravenous fluid therapy is a fundamental treatment in intensive care units (ICUs). Although most clinical trials have focused on patients requiring active resuscitation of the intravascular volume, such as those...

Original Article

December 27, 2024

Direct co-culture with human neural stem cells suppresses hemolysate-induced inflammation in RAW 264.7 macrophages through the extracellular signal-regulated kinase pathway

Tae Jung Kim, Jing Sun, Lami Kang, Young-Ju Kim, Sang-Bae Ko, Byung-Woo Yoon

J Neurocrit Care. 2024;17(2):49-56.

Background: Inflammation following stroke is associated with poor outcomes, and the anti-inflammatory effects of neural stem cells (NSCs) have been reported. However, the direct immunomodulatory effects of NSCs in hemorrhagic...

Current Issue: Volume 17(2); Dec 2024

Volume 17, No. 2

E-Submission

Endnote Style File

Endnote Style File

Email Alert

Author's Index

SCImago Journal & Country Rank

Video clip

Supranuclear oculomotor palsy in cerebral venous sinus thrombosis: a case report. J Neurocrit Care. 2021;14:113-116

The author of the accepted manuscript will receive two mugs, printed with an abstract design. We look forward to your continued interest in and support for this journal.

Korean Neurocritical Care Society

First decision

24 Days

Publication after acceptance

29 Days

Submission to publication

77 Days

Acceptance rate

40 %

*Last 12 months

Editorial Office
Department of Neurology and Critical Care, Seoul National University Hospital,
101, Daehak-ro, Jongno-gu, Seoul, 03080 Korea
TEL: +82-2-2072-0743 (10:00 AM ~ 4:00 PM) / +82-2-2072-1810 FAX: +82-2-3672-7553 E-mail: office@e-jnc.org

Copyright© Korean Neurocritical Care Society.

Developed in M2PI